LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 3 | M20 | 72 | hr | 1694 | 2511 | 11168 | 0.2248 | 0.1556 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 1 | M19 | 72 | hr | 1694 | 2791 | 11042 | 0.2528 | 0.2027 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 2 | M19 | 72 | hr | 1694 | 2476 | 11099 | 0.2231 | 0.1502 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 3 | M19 | 72 | hr | 1694 | 2542 | 11168 | 0.2276 | 0.1608 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 1694 | 10433 | 11220 | 0.9298 | 0.9473 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 1694 | 9836 | 11309 | 0.8697 | 0.9006 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 1694 | 9748 | 11121 | 0.8765 | 0.9052 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1694 | 6566 | 11220 | 0.5852 | 0.6433 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1694 | 7387 | 11309 | 0.6532 | 0.7120 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1694 | 7018 | 11121 | 0.6311 | 0.6880 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1694 | 3439 | 11220 | 0.3065 | 0.2964 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1694 | 3949 | 11309 | 0.3492 | 0.3620 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1694 | 4015 | 11121 | 0.3610 | 0.3742 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 1694 | 2230 | 11220 | 0.1987 | 0.1060 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 1694 | 2396 | 11309 | 0.2119 | 0.1349 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 1694 | 2154 | 11121 | 0.1937 | 0.0925 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 1694 | 2521 | 11220 | 0.2247 | 0.1569 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 1694 | 2654 | 11309 | 0.2347 | 0.1781 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 1694 | 2251 | 11121 | 0.2024 | 0.1103 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 1694 | 2280 | 11220 | 0.2032 | 0.1150 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 1694 | 2356 | 11309 | 0.2083 | 0.1279 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 1694 | 2293 | 11121 | 0.2062 | 0.1179 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 1694 | 11410 | 11042 | 1.0333 | 1.0244 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 1694 | 11263 | 11099 | 1.0147 | 1.0108 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 1694 | 11425 | 11168 | 1.0230 | 1.0168 |